ISSN:
1432-1440
Keywords:
Trypsin inhibitors
;
Tumor markers
;
Pancreatic enzymes
;
Pancreatic cancer
;
Chronic pancreatitis
Source:
Springer Online Journal Archives 1860-2000
Topics:
Medicine
Notes:
Summary Serum TATI (tumor-associated trypsin inhibitor) was measured in 41 control subjects, 30 patients with pancreatic cancer, 53 with chronic pancreatitis, and 47 with extrapancreatic diseases, mainly of gastrointestinal origin. TATI was found to be elevated in some subjects in all groups of patients; patients with chronic pancreatitis studied during an acute exacerbation of the disease had the highest percentage (68%) of pathological values. TATI was found to be correlated with elastase 1, tissue polypeptide antigen, and total and pancreatic isoamylase. A significant relationship was also found between TATI and serum creatinine levels.
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1007/BF01727004
Permalink